Markus Müller
Impact in
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Oncology 41
- Drug Transport and Resistance Mechanisms 39
- Pharmacology 40
- Antibiotics Pharmacokinetics and Efficacy 39
- Co-authors
- Martin Brunner (31 shared papers)Oliver Langer (47 shared papers)Christian Joukhadar (25 shared papers)Hartmut Derendorf (7 shared papers)Markus Zeitlinger (29 shared papers)Hans Georg Eichler (13 shared papers)Bernhard X. Mayer (11 shared papers)Martin Frossard (9 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (11 papers)European Journal of Clinical Pharmacology (5 papers)Nuclear Medicine and Biology (5 papers)Clinical Pharmacology & Therapeutics (5 papers)The Journal of Clinical Pharmacology (4 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Markus Müller
129 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 133
- Pharmacology 1.5k
- Molecular Medicine 364
- Applied Microbiology and Biotechnology 127
- Clinical Biochemistry 364
- Pharmaceutical Science 338
Countries citing papers authored by Markus Müller
This map shows the geographic impact of Markus Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Müller more than expected).
Fields of papers citing papers by Markus Müller
This network shows the impact of papers produced by Markus Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Müller. The network helps show where Markus Müller may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 250 | |
| 2 | 2001 | 227 | |
| 3 | 2004 | 210 | |
| 4 | 2002 | 160 | |
| 5 | 2007 | 104 | |
| 6 | 2002 | 103 | |
| 7 | 2009 | 101 | |
| 8 | 2013 | 97 | |
| 9 | 2009 | 95 | |
| 10 | 2006 | 92 | |
| 11 | 2009 | 91 | |
| 12 | 2001 | 89 | |
| 13 | 2008 | 87 | |
| 14 | 2000 | 85 | |
| 15 | 2013 | 85 | |
| 16 | 2000 | 80 | |
| 17 | 2000 | 78 | |
| 18 | 2006 | 78 | |
| 19 | 2001 | 75 | |
| 20 | 2007 | 74 |
About Markus Müller
Markus Müller is a scholar working on Oncology, Pharmacology, Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Epidemiology, having authored 130 papers that have together received 5.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (39 papers), Drug Transport and Resistance Mechanisms (39 papers), Pharmacological Effects and Toxicity Studies (21 papers), Antibiotic Resistance in Bacteria (8 papers), Epilepsy research and treatment (8 papers), Advancements in Transdermal Drug Delivery (8 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Bacterial Identification and Susceptibility Testing (7 papers). The work is most often cited by research in Pharmacology (1.5k citations), Molecular Medicine (364 citations), Applied Microbiology and Biotechnology (127 citations), Clinical Biochemistry (364 citations) and Pharmaceutical Science (338 citations). Markus Müller has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Martin Brunner, Oliver Langer, Christian Joukhadar, Hartmut Derendorf, Markus Zeitlinger, Hans Georg Eichler, Bernhard X. Mayer, Martin Frossard, Johann Stanek and Claudia Kuntner. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, European Journal of Clinical Pharmacology, Nuclear Medicine and Biology, Clinical Pharmacology & Therapeutics and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.